MHRA-2022-0068-V268

Type IA variation for application MHRA-2022-0068. Type IA variation: Manufacturing Process Change for Crizotinabex — major revision

Variation Number
MHRA-2022-0068-V268
Type
Type IA
Application
MHRA-2022-0068
Change
CHG-2021-0268
Status
Overdue
Fee
€3,500
Submitted
—
Approved
—
Description

Type IA variation: Manufacturing Process Change for Crizotinabex — major revision